Autocrine GH stimulates WNT4 expression in breast cancer cells, which, in turn, increases mesenchymal markers vimentin, MMP2, and MMP7, while inducing cell migration and suppressing apoptosis (58). Here, GH1 is linked to breast carcinoma.